Wide Awake Facial Reconstruction: A Literature Review, Cost Analysis, and Practical Guide Authors: Aidan Shulkin, Yossi Cohen, Gabriel Bouhadana, Jordan Gornitsky, Daniel E. Borsuk Published: 2026 ABSTRACT Background:General anesthesia (GA) has been the standard for complex facial reconstructive surgery but is associated with perioperative risks and increased resource consumption. Wide awake facial reconstruction (WAFR), performed under local anesthesia (LA)/regional anesthesia (RA), offers an alternative that avoids these limitations. Nonetheless, WAFR remains underreported, and best practices are not well established.Methods:A literature review was conducted to identify studies involving WAFR, from which data were analyzed. Additionally, the costs of performing forehead flap reconstruction using LA/RA were compared with those under GA. Finally, a practical guide was developed to highlight key strategies for optimizing patient comfort.Results:Thirty studies involving 1249 patients and 1262 flaps were included. Forehead (n = 443, 35.1%) and nasolabial (n = 387, 30.7%) flaps were the most frequently implemented. Minor (n = 126, 10.0%) and major (n = 34, 2.7%) complications were uncommon. Most patients expressed minimal to no pain during surgery and were consistently satisfied with their experience. No conversions to GA were required. The total cost of performing a forehead flap using WAFR is considerably lower when compared with GA ($1280.03 versus $6646.74; difference: $5366.71).Conclusions:WAFR is a safe, well-tolerated and effective alternative to facial reconstruction under GA. Advanced procedures, such as loco-regional flaps, can be successfully performed under LA/RA. This approach also improves access to revision surgery, a key factor in achieving the best possible final outcomes. The avoidance of GA significantly reduces healthcare costs. Further research is needed to incorporate patient-reported outcomes and expand the role of WAFR across diverse techniques. Takeaways Question: Does Wide Awake Facial Reconstruction (WAFR) reduce healthcare costs while maintaining gold-standard outcomes in the treatment of facial deformities? Findings: A literature review of 30 studies (1249 patients, 1262 flaps) demonstrated low complication rates, high patient satisfaction, and no conversions to GA. Forehead flap reconstruction using WAFR resulted in $5366.71 in cost savings compared with GA. A practical step-by-step guide was developed to enhance patient comfort. Meaning: WAFR is a safe, well-tolerated and effective alternative to facial reconstruction under GA. INTRODUCTION Facial reconstructive surgery is essential for restoring form and function following oncologic resection, trauma, and other acquired defects, and plays an important role in patient quality of life.1,2 Although minor defects are typically repaired primarily under local anesthesia (LA)/regional anesthesia (RA), more complex interventions, such as locoregional flaps, are less commonly attempted in this setting, and frequently require general anesthesia (GA).3,4 Recently, however, both LA and RA have gained traction as viable alternatives for select patients requiring advanced facial reconstruction.5–7 At our institution, wide awake facial reconstruction (WAFR), defined as facial reconstructive surgery performed under LA/RA without GA, has become standard practice. WAFR is particularly advantageous in older adult or comorbid patients, who are both disproportionately affected by facial lesions and often deemed poor candidates for GA.8–12 Moreover, the use of LA/RA has proven to be a cost-effective alternative, necessitating less personnel and anesthetic materials/drugs, and eliminating the need for a formal operating room (OR) and monitoring, ultimately decreasing the use of healthcare system resources.13–17 Despite these advantages, WAFR remains underutilized, and best practices are not well defined in the literature. This article aimed to comprehensively review the existing literature on WAFR, highlighting current practices, complications, and outcomes. Additionally, we present a cost-analysis comparing WAFR to GA for forehead flap reconstruction, illustrating the potential economic advantages of this approach in clinical practice. Finally, we provide an overview of our institutional technique, focusing on key procedural considerations to maximize patient comfort. METHODS Literature Review A comprehensive literature review was conducted in July 2025 using the PubMed database. The following search terms were applied in English: (“local” AND anesth*) AND (“face” OR “facial” OR “nose” OR “nasal”) AND (reconstruct* OR “repair” OR “flap”). Studies were included if they reported on the use of LA/RA for advanced facial reconstructive surgery in adult patients (>18 years of age). Eligible procedures involved local or regional flaps used to repair defects of the nose, cheek, peri-oral, peri-orbital, or forehead regions following oncologic resection or other acquired causes. Studies were excluded if they focused solely on aesthetic procedures (eg, facelift, rhinoplasty, blepharoplasty); reconstruction of the scalp, ear, or oral cavity; or minimally invasive techniques (eg, primary closure, skin grafting, dermal regeneration matrices). Additionally, studies that did not stratify outcomes by anesthesia type were excluded when applicable. No restrictions were placed on publication date or language. Search results were imported into Covidence for screening.18 After removing duplicates, titles/abstracts were reviewed, and full texts of potentially relevant studies were assessed based on inclusion/exclusion criteria. Although no language restrictions were applied, all retrieved studies presented their titles/abstracts in English, and only 2 full-text manuscripts were published in French. Data extracted from eligible studies included patient characteristics, surgical techniques, complications, and outcomes (ie, pain, satisfaction, and aesthetics). All included studies were subsequently appraised using the Oxford Centre for Evidence-Based Medicine Levels of Evidence.19 Cost Analysis A cost analysis was conducted to evaluate the economic impact of performing a forehead flap using LA/RA, in a minor procedure room (MPR), compared with GA, in a traditional OR. This was based on a standardized procedural model, constructed using two representative scenarios rather than relying on case-based averages. The analysis considered three primary categories: infrastructure, materials, and personnel. Infrastructure costs encompassed overhead expenses related to the MPR, OR, surgical day center, and postanesthesia care unit, with data drawn from local institutional accounting estimates. Material costs included expenses for personal protective equipment, disposable surgical supplies, and anesthesia-related items, based on our local institution’s pricing catalog. Personnel costs were determined according to the staffing needs specific to each anesthetic approach and were calculated using standardized wage data from the Régie de l’Assurance Maladie du Québec20 and the Government of Canada Job Bank.21 All costs were expressed in 2025 Canadian dollars. Finally, the total estimated cost per procedure was compared between LA/RA and GA. Practical Guide Based on the findings of our literature review, insights from the wide awake anesthesia no tourniquet technique, and our clinical experience, we developed a step-by-step practical guide to performing WAFR with a focus on optimizing patient comfort. RESULTS Included Studies A total of 528 records were identified through the database search. After title/abstract screening, 107 full-text articles were assessed for eligibility. Following the application of inclusion/exclusion criteria, 30 studies were included in the final review22–51 (Fig. 1). Flow diagram illustrating the identification, screening, eligibility assessment, and inclusion of studies in our review. Of the included studies, 19 (63.3%) were retrospective/prospective cohort in design and 17 (56.7%) were classified as level of evidence 3. Europe was the most prevalent region of origin (n = 10, 33.3%), followed by North America (n = 9, 30.0%). Most studies were published between 2010-2019 (n = 12, 40.0%), and after 2019 (n = 8, 26.7%) (overview in Table 1; individual characteristics in Supplemental Digital Content 1). (See, table, Supplemental Digital Content 1, which displays the summary of included studies involving the use of WAFR, detailing individual study characteristics such as authors, country, design, and levels of evidence, https://links.lww.com/PRSGO/E874.) Table 1.Studies Reporting the Use of WAFR (Overview of Study Characteristics).CharacteristicSpecificationn (%), Total (N = 30)DesignCohort19 (63.3)Case report7 (23.3)Case series4 (13.3)RegionEurope10 (33.3)North America9 (30.0)Asia6 (20.0)Middle East3 (10.0)South America1 (3.3)Oceania1 (3.3)Levels of evidence22 (6.7)317 (56.7)411 (36.7)Year of publication≥20208 (26.7)2010–201912 (40.0)2000–20096 (20.0)<20004 (13.3) Studies Reporting the Use of WAFR (Overview of Study Characteristics). Patient Characteristics and Procedures Overall, 1249 patients underwent 1262 locoregional flaps using WAFR. The mean reported age of patients was 65 years (range: 22–95 y). Most patients required facial reconstruction secondary to tumor resection (n = 1247, 99.8%). The primary anatomical site of reconstruction was unspecified in most cases (n = 724, 58.0%), followed by the nose (n = 393, 31.5%). Interpolated flaps were the most frequently implemented, including forehead flaps (n = 443, 35.1%), and nasolabial/melolabial flaps (n = 387, 30.7%). The most common local anesthetic used was 1% lidocaine with epinephrine (1:100,000) (n = 729, 57.8%) (overview in Table 2; individual characteristics in Supplemental Digital Content 2). (See, table, Supplemental Digital Content 2, which displays the summary of included studies involving the use of WAFR, detailing individual patient characteristics, procedures, and outcomes, https://links.lww.com/PRSGO/E875.) Table 2.Studies Reporting the Use of WAFR (Overview of Patient Characteristics and Procedures)CategorySpecificationn (%)EtiologyTumor excision1247 (99.8)Postburn contracture release1 (0.1)Necrosis due to skin ailment1 (0.1)Total1249 (100.0)Primary anatomical site of reconstructionFace/nonspecified724 (58.0)Nose393 (31.5)Cheek49 (3.9)Peribuccal48 (3.8)Periorbital20 (1.6)Forehead/glabella15 (1.2)Total1249 (100.0)FlapsInterpolated flapsForehead443 (35.1)Nasolabial/melolabial387 (30.7)Retroauricular60 (4.8)Paranasal40 (3.2)Nonclassifiable8 (0.6)Advancement flaps*79 (6.3)Rotation flaps†68 (5.4)Transposition flaps‡58 (4.6)Island flaps§44 (3.5)Mixed local flaps∥43 (3.4)Other¶23 (1.8)Nonclassifiable**9 (0.7)Total1262 (100.0)Anesthesia1% lidocaine with epinephrine (1:100,000)729 (57.8)Tumescent solution79 (6.3)2% lidocaine with epinephrine (1:200,000)5 (0.4)4% tetracaine (topical), 1% diphenhydramine (s/c)1 (0.1)Nonspecified448 (35.5)Total1262 (100.0)*Nonspecific advancement flaps, V-Y flaps, Rintala flaps, and lateral nasal advancement flaps.†Nonspecific rotation flaps and upper lateral lip rotation flaps.‡Nonspecific transposition flaps, Limberg flaps, and retroangular flaps.§Nonspecific island flaps, island nasal flaps, island mucochrondrocutaneous nasal wall flaps, island myocutaneous nasal root flaps, and shark island pedicle flaps.∥Nonspecific local flaps, modified reading man flaps, advancement-rotation cheek flaps, reading man flaps, and sliding rotation flaps.¶Bilobed zygomatic and lateral cheek flaps, Abbe/Abbe-Estlander flaps, nonspecific myocutaneous flaps, modified Webster flaps, and modified cervicofacial flaps.**Nasolabial flaps, Mustarde-type cheek advancement flaps, and bilobed flaps (the authors did not report individual quantities separately, but instead presented them as a combined total). Studies Reporting the Use of WAFR (Overview of Patient Characteristics and Procedures) Nonspecific advancement flaps, V-Y flaps, Rintala flaps, and lateral nasal advancement flaps. Nonspecific rotation flaps and upper lateral lip rotation flaps. Nonspecific transposition flaps, Limberg flaps, and retroangular flaps. Nonspecific island flaps, island nasal flaps, island mucochrondrocutaneous nasal wall flaps, island myocutaneous nasal root flaps, and shark island pedicle flaps. Nonspecific local flaps, modified reading man flaps, advancement-rotation cheek flaps, reading man flaps, and sliding rotation flaps. Bilobed zygomatic and lateral cheek flaps, Abbe/Abbe-Estlander flaps, nonspecific myocutaneous flaps, modified Webster flaps, and modified cervicofacial flaps. Nasolabial flaps, Mustarde-type cheek advancement flaps, and bilobed flaps (the authors did not report individual quantities separately, but instead presented them as a combined total). Complications Minor complications were observed in 10.0% of cases, mainly attributable to epidermolysis (n = 50, 4.0%) and surgical site infections requiring antibiotics (n = 27, 2.1%). Major complications were observed in only 2.7% of cases, including partial necrosis (n = 26, 2.0%) and total necrosis (n = 5, 0.4%) (overview in Table 3). Table 3.Studies Reporting the Use of WAFR (Overview of Complications)ComplicationsSpecificationn (%)Minor complicationsEpidermolysis50 (4.0)Infection27 (2.1)Hypertrophic scarring9 (0.7)Hematoma8 (0.6)Dehiscence8 (0.6)Chondritis6 (0.5)Dermatitis6 (0.5)Cyst3 (0.2)Conjunctival irritation3 (0.2)Granuloma2 (0.2)Hypergranulation2 (0.2)Nasal obstruction2 (0.2)Total126 (10.0)Major complicationsPartial necrosis26 (2.0)Total necrosis5 (0.4)Major bleeding3 (0.2)Total34 (2.7) Studies Reporting the Use of WAFR (Overview of Complications) Pain Three studies utilized custom pain scales. One study including 62 patients reported that 95% experienced only mild pain during infiltration, and 90% had no pain during the procedure itself. The remaining patients experienced moderate but tolerable discomfort.22 Similarly, another study assessing 22 patients found mean pain scores of 3.4 of 5 during infiltration, 1.9 of 5 during surgery, and 2.8 of 5 postoperatively.46 A third study comprising 39 patients reported that both intraoperative and postoperative pain and anxiety levels were consistently minimal to mild.49 One study involving 12 patients relied on subjective observations and noted that no pain was observed during surgery, whereas fewer than half reported slight to moderate pain during the night following the procedure.39 Notably, no studies reported intolerable pain during the infiltration, during surgery, or postoperatively, and no conversion from LA/RA to GA was required. Satisfaction Overall, patient satisfaction with the WAFR approach was consistently high. In one study including 35 patients, all who underwent an initial procedure using LA/RA opted for subsequent revisions with the same technique.25 Another study assessing 22 patients reported favorable satisfaction ratings, with mean scores of 4.3 of 5 for convenience, 3.8 of 5 for perceived efficacy, and 3.4 of 5 for comfort. When asked about future procedures, the majority of patients expressed willingness to undergo WAFR again.46 Perioperative satisfaction was also elevated in a separate study comprising 39 patients, with a mean score of 95 of 100.49 Aesthetics Aesthetic results following WAFR were consistently rated favorably across studies, regardless of the flap design implemented. In one study including 62 patients, 90% rated their outcomes as “good” and 10% as “excellent” following reconstruction with a range of local flaps.22 This aligns with findings from other studies employing various techniques in 705 patients, where 94%–97% were reported to have “good,” “satisfactory,” or “excellent” aesthetic outcomes.34,35 A study using transposition flaps in 13 patients reported a high mean aesthetic score of 9.38 of 10 (range: 8–10) on a visual analog scale.31 In another study utilizing paramedian forehead and other local flaps in 22 patients, the mean custom aesthetic rating was 4 of 5, and the mean FACE-Q score was 83.9 of 100.46 Cost Analysis Infrastructure ($84.32 versus $4549.33; difference: $4465.01), material ($54.96 versus $276.75; difference: $221.79), and personnel costs ($1140.75 versus $1820.66; difference: $679.91) were all substantially lower when using LA/RA for forehead flap reconstruction compared with GA. Overall, this translates to an approximate 80.1% cost savings ($1280.03 versus $6646.74; difference: $5366.71) (overview in Table 4; material costs in Supplemental Digital Content 3 and 4). (See table, Supplemental Digital Content 3, which displays the summary of material cost components for forehead flap reconstruction performed under LA/RA, detailing expenditures related to personal protective equipment (PPE), anesthesia, surgery, and other associated items, https://links.lww.com/PRSGO/E876.) (See table, Supplemental Digital Content 4, which displays the summary of material cost components for forehead flap reconstruction performed under GA, detailing expenditures related to PPE, anesthesia, surgery, and other associated items, https://links.lww.com/PRSGO/E877.) Table 4.Cost Analysis of Forehead Flap Reconstruction Using LA/RA Versus GAWAFR ($)GA ($)Cost Savings ($)InfrastructureMPR/OR84.321797.92SDC/PACU—2751.41Total84.324549.334465.01MaterialPPE9.3311.49Anesthesia6.93226.01Surgery37.0937.09Other1.612.16Total54.96276.75221.79PersonnelSurgeon1061.851061.85Nurses66.08330.40Anesthesiologist-336.00RT-66.78Orderlies12.8225.63Total1140.751820.66679.91Total1280.036646.745366.71PACU, postanesthesia care unit; RT, respiratory therapist; SDC, surgical day center. Cost Analysis of Forehead Flap Reconstruction Using LA/RA Versus GA PACU, postanesthesia care unit; RT, respiratory therapist; SDC, surgical day center. DISCUSSION Rationale and Key Findings The prevalence of facial skin cancer continues to increase, particularly among older individuals.52,53 Given that advanced age presents a risk for perioperative complications, the use of GA in this demographic introduces further challenges and concerns.8–12 In parallel, rising medical costs underscore the need to adopt strategies that reduce strain on the healthcare system.54,55 Facial reconstruction foregoing systemic anesthetic techniques has proven to be one of those avenues. Although underrepresented in the literature, our findings support WAFR as a safe, well-tolerated and effective technique. A variety of reconstructive procedures have been successfully performed under LA/RA, with low complication rates, little to no pain, and consistently high patient satisfaction. An additional advantage of this approach is facilitated access to an operative setting, allowing surgeons to offer patients revision surgery more freely and, thus, the best possible final results. Avoidance of GA The potential risks associated with GA in older adult patients undergoing surgery warrant careful consideration. Age-related declines in organ reserve, combined with the presence of comorbidities, contribute to a heightened risk of perioperative complications, including cardiovascular, respiratory, renal, and neurological events.9,11,12 Among these, delirium and cognitive dysfunction are particularly concerning, as they can significantly delay recovery and are linked to increased morbidity/mortality.8 Additional GA-related complications such as nausea, vomiting, and airway challenges further add to the burden of care.13 In contrast, many facial reconstructive procedures, despite their complexity and duration, can be safely and effectively performed under LA/RA, provided the patient is well-prepared, cooperative and appropriately selected,10 as demonstrated in our findings. Reduced Resource Utilization and Cost Savings A systematic review comparing procedures performed under LA/RA versus GA reported substantial cost savings for a wide variety of interventions.16 These savings were primarily attributed to the elimination of formal OR use, reduced need for postanesthesia monitoring, and shorter hospital stays. Our findings align with these observations, demonstrating that performing forehead flap reconstruction under LA/RA results in an approximate cost reduction of 80.1%, largely due to the same contributing factors. Furthermore, although not explicitly calculated in our study, the true cost of surgery under GA is likely even higher when accounting for opportunity cost, namely, the use of limited OR resources that could otherwise be allocated to more complex cases.56 Additionally, indirect costs to patients, such as lost income or reduced productivity may further contribute to the overall financial burden. Infection Control Achieved in Minor Procedure Settings Recent studies have demonstrated that performing procedures in MPRs with less stringent regulations, compared with traditional ORs, does not increase the postoperative infection risk.57–60 In our study, the infection rate was 2.1%, comparable to published rates for facial reconstruction under GA, which range from 1.5% to 6.5%.61,62 Because most infections were derived from isolated cohorts,25,35,38,45 we believe the true infection rate is likely even lower. These findings support that, when established guidelines are followed and sterility protocols are strictly adhered to,63–66 infections can be effectively avoided. It is worth mentioning that careful attention should be given to vulnerable groups, including immunocompromised patients, older individuals, and those with other risk factors/comorbidities, as they often represent a substantial portion of the facial reconstructive population.67–69 Management of Antiplatelet and Anticoagulant Therapy The perioperative management of antithrombotic agents is an important aspect of surgical care and requires particular attention in the context of WAFR.70 In our experience, patients can safely continue antiplatelet therapy, such as aspirin, a practice supported by existing evidence.71,72 However, we elect to discontinue anticoagulation, as the associated risks, including uncontrolled bleeding, impaired visualization of the operative field, and increased psychological distress for wide awake patients, justify a more cautious approach.71 Decisions regarding continuation/cessation should be made in consultation with internal medicine or other relevant specialties, ensuring an individualized plan that reflects each patient’s specific risk profile.73,74 If cessation is not recommended, the choice to proceed with WAFR ultimately relies on surgeon preference, provided that appropriate caution is maintained.75 Expanding the Boundaries Although WAFR has typically been reserved for conventional locoregional flaps, recent reports suggest a broader range of applications, including more advanced and challenging reconstructions. One study reported the use of LA/RA for the repair of a full-thickness lower lip defect using a modified Webster flap in a 68-year-old patient.50 In another report, a modified cervicofacial flap was successfully performed under LA/RA to close a large cheek defect.43 These cases highlight the growing interest in extending WAFR principles to complex reconstructions and underscore its safety and feasibility, particularly in older adult patients with multiple comorbidities. It is important to note that as reconstructions become more extensive, the volume of LA required will inevitably increase. Careful attention must be given to cumulative dosing to remain within established safety limits and prevent systemic toxicity.76,77 Measures to avoid these complications include employing targeted regional blocks, using epinephrine-containing or diluted solutions, and administering anesthesia in incremental doses. Considerations to Maximize Patient Comfort Despite its many advantages, WAFR is not without limitations and important considerations. A key concern for surgeons is patient compliance. Even with adequate preoperative counseling, anxiety and fear may remain a barrier to smooth, complication-free surgery. To address these challenges, several strategies can be used (Table 5). Table 5.WAFR Technique to Optimize Patient ComfortStepDetails1Ensure the patient is lying down comfortably; provide warm blankets and pillows for added comfort.2Offer the patient a choice of music and engage in light, friendly conversation to help reduce residual stress and create a calm environment.3Apply topical anesthetic cream (eg, benzocaine/tetracaine/lidocaine mixture) to the injection site.Wait approximately 30 minutes before proceeding.4Combine 1 mL of sodium bicarbonate, 7 mL of 1% lidocaine with epinephrine (1:100,000), and 3 mL of 0.5% bupivacaine using an 18G needle.5Deliver the anesthetic solution slowly while applying sensory distraction (eg, skin pinching) around the injection site, following alcohol-based local disinfection.Use a 32G needle for initial, superficial injections, followed by a 30G needle for deeper structures.Perform a regional block of V1 and/or V2 before injecting into the wound, following standard anatomical landmarks.Allow for at least 5 minutes in between to give time for the regional block to take place, minimizing pain at the local site(s).Inject local anesthetic through the open parts of the wound first, followed by injections in the adjacent regions.Wait at least 5 minutes before the first incision to allow for optimal vasoconstrictive and anesthetic effects.6Proceed with disinfection using a clear 0.05% aqueous chlorhexidine solution (eg, Irrilin), carefully avoiding leakage of solution into the eyes, ears, nose, or neck.7Drape appropriately while keeping the entire face exposed.This maximizes visualization of the defect, facilitates assessment of symmetry and changes, andenhances patient comfort.8Cover the patient’s eyes with moist gauze to decrease discomfort from the surgical lights.9Verify anesthesia at the operative site through gentle skin pinching with forceps and asking if the patient is experiencing sharp pain.It is essential to distinguish between pain and pressure/tactile sensation, as local anesthesia does not eliminate the latter.10Maintain open and reassuring communication with the patient throughout the procedure to enhance comfort and cooperation.11Supplement local anesthetic as needed throughout the surgery.12Consider administering sublingual benzodiazepines (eg, lorazepam) in select patients to reduce anxiety and improve cooperation when necessary. WAFR Technique to Optimize Patient Comfort Reassuring communication and the use of appropriate language can help establish trust and maintain patient engagement.78 In addition, playing calm music before and during the procedure may create a more soothing environment.79 Warm blankets and pillows may also provide an added level of comfort.80 In select cases, benzodiazepines may be considered to reduce anxiety and enhance cooperation, though their use should be limited to carefully chosen individuals due to potential side effects.50 Ensuring the proper technique for administering LA/RA is arguably the most critical aspect of WAFR, as a pain-free first-hand experience is essential for maintaining patient cooperation. The goal is to limit discomfort to the initial needle prick, ensuring that the patient feels no pain throughout the rest of the anesthetic administration or the procedure.81 Applying topical anesthetic creams (eg, benzocaine/tetracaine/lidocaine mixture) before injection may provide pain relief during needle insertion.82,83 A waiting period of approximately 30 minutes should be observed before proceeding.84 One key technique involves buffering the LA with sodium bicarbonate, which reduces its acidity and the associated burning sensation during injection.85 Another method uses sensory distraction, such as vibration devices or skin pinching, to downregulate nerve fibers responsible for transmitting pain signals.86,87 Moreover, the use of small gauge needles (eg, 30G, 32G) is preferred for injections, as it further reduces discomfort.88 In our experience, we use a 32G needle for initial, superficial injections, followed by a 30G needle for deeper structures. A regional block targeting the V1 and/or V2 branches should be performed before injecting the open wound and surrounding tissue. To ensure optimal anesthetic and vasoconstrictive effects, a waiting period of approximately 5 minutes should be observed between administration of the LA/RA and the first incision.89 Before proceeding, the surgeon should gently test the anesthetized region using forceps. At this stage, disinfection should be performed using a clear antiseptic solution, carefully avoiding leakage into the eyes, ears, nose, or neck. Appropriate draping should be applied, leaving the entire face exposed. This maximizes visualization of the defect, facilitates assessment of symmetry and changes, and enhances patient comfort. Moist gauze compresses can be positioned on top of the patient’s eyes to decrease discomfort associated with the surgical lights. During the procedure, local anesthesia should be administered as necessary. Strengths and Limitations To our knowledge, this study represents the most comprehensive synthesis of WAFR to date, integrating a literature review, cost analysis, and practical guide within a single framework. However, several limitations must be acknowledged. Most included studies were retrospective cohorts or case series/reports, which introduces the potential for bias. It must also be noted that key outcomes such as pain and satisfaction were available from only a limited number of studies and were often measured using nonvalidated instruments. Additionally, our cost-analysis reflects the practices of a single institution, which may limit its generalizability to other healthcare settings/regions. Furthermore, the cost estimates were derived from a standardized procedural model rather than case averages. Although this does not account for variability, it still provides a reliable basis for evaluating relative cost differences. CONCLUSIONS WAFR represents a safe, well-tolerated, and effective alternative to traditional facial reconstruction under GA. Our findings demonstrate that advanced procedures, such as locoregional flaps, can be successfully performed under LA/RA, with low complication rates, little to no pain, and high patient satisfaction. This approach also improves access to revision surgery, a key factor in achieving the best possible final outcomes. In addition, avoiding GA significantly reduces resource utilization and healthcare costs while mitigating risks that disproportionately affect older adult and comorbid patients. Despite these promising outcomes, there remains a notable gap in the literature. Future research should incorporate patient-reported outcome measures and explore strategies to optimize the patient experience. In this context, we propose a practical guide aimed at standardizing perioperative care and enhancing patient comfort throughout the reconstructive process. Continued investigation is also necessary to further define and expand the boundaries of WAFR across a broader range of reconstructive techniques. DISCLOSURE The authors have no financial interest to declare in relation to the content of this article. Supplementary Material